Results 91 to 100 of about 3,798 (162)

Management of hepatorenal syndrome and associated outcomes: a systematic review

BMJ Open Gastroenterology
Background Hepatorenal syndrome (HRS), a multiorgan condition of acute kidney injury, is seen in advanced liver disease. This study aims to evaluate the current treatment for HRS.Methods The authors searched PubMed, Scopus and Google Scholar literature ...
Anahid Hamidianjahromi, Jamshid Roozbeh, Shahrokh Ezzatzadegan Jahromi, Mohamad Hossein Rezazadeh, Leila Malekmakan   +4 more
doaj   +1 more source

The current applications and future directions of terlipressin

Terlipressin is a vasopressin analog with potent splanchnic vasoconstrictor properties. It has an established role in managing portal hypertensive bleeding and hepatorenal syndrome-acute kidney injury, with a growing body of evidence demonstrating ...
Majumdar, A, Sinclair, M, Liu, D, Testro, A   +3 more
core   +1 more source

Intraoperative risk of bleeding and its prevention during transcervical myomectomy [PDF]

Medičnì Perspektivi, 2014
In this study clinical, functional and morphological assessment of the effectiveness of synthetic analogue of vasopressin (terlipressin) has been made.
Kaminsky V.V., Dunaevska V.V., Medvediev M.V.   +2 more
doaj  

Embolia cutis medicamentosa: An unusual adverse reaction to terlipressin

, 2017
Terlipressin is a synthetic long-acting analog of vasopressin widely used to control variceal bleeding by lowering portal venous pressure. We report an unusual adverse reaction to terlipressin in a 78-year-old patient with esophageal variceal bleeding ...
Triantafyllou, K., Dimitriadis, G.D., Panayiotides, I.G., Gatos-Gatopoulos, P., Kostantoudakis, S.   +4 more
core   +1 more source

Continuous Terlipressin Infusion as Rescue Treatment in a Case Series of Children with Refractory Septic Shock

, 2010
Background: Despite intensive therapy, refractory pediatric septic shock has a high rate of morbidity and mortality. Additional treatments are needed to improve outcomes in such cases.
Mireia Gaboli, Jesús López-Herce, Antonio Rodríguez-Núñez, César Pérez-Caballero, Ignacio Oulego-Erroz, Javier Gil-Antón, Guillermo Milano   +6 more
core   +1 more source

Effectiveness and safety evaluation of terlipressin in the treatment of intestinal paralysis in end-stage liver disease

BMC Gastroenterology
Background and aims Intestinal paralysis is a common complication in end-stage liver disease (ESLD), our aim is to assess the effectiveness and safety of low-dose terlipressin for treating intestinal paralysis in ESLD.
Xia Wan, Hua Xu, Hu Li, Shan Zhong, Yu Lei, Huan Deng, Xiao Fu, Zhi Zhou   +7 more
doaj   +1 more source

Effekte einer Kombination von Terlipressin und Dopexamin gegenüber einer alleinigen Terlipressinapplikation im endotoxämischen Schafmodell

, 2014
Im katecholaminresistenten septischen Schock werden Vasopressinrezeptoragonisten wie Terlipressin benutzt. Diese beeinträchtigen das Herzzeitvolumen, den Sauerstoffverbrauch, führen zur pulmonalarteriellen Hypertonie und zu Mikrozirkulationsstörungen ...
Schubert, S. (Sebastian)
core   +1 more source

The role of terlipressin in pediatric septic shock: A review of the literature and personal experience

, 2007
Vasopressin and its synthetic analog terlipressin are potent vasopressors that could be useful in vasodilatory septic shock. In septic adults, vasopressin/terlipressin have been shown to increase mean arterial pressure and to decrease the necessity for ...
Barbara Cs, Mancuso M., PAPOFF, PAOLA, MORETTI, Corrado   +3 more
core  

Nonintensive Care Unit Norepinephrine as an Alternative to Terlipressin in Hepatorenal Syndrome-Acute Kidney Injury. [PDF]

Gastro Hep Adv
Rajasekaran V, Cheng XS, Akama-Garren E, Garcia J, Phillips J, Deng K, Wang U, Sola E, Jalil S, Kwo P, Kwong AJ.   +10 more
europepmc   +1 more source

Real-world safety of terlipressin in elderly patients with liver cirrhosis and esophagogastric variceal bleeding: a focus on hyponatremia and administration methods. [PDF]

Front Pharmacol
Peng Y, Li J, Li M, Duan H, Peng R, Zuo P.   +5 more
europepmc   +1 more source